-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Reiterates Outperform on Tyra Biosciences, Maintains $53 Price Target

Benzinga·09/10/2026 13:00:52
Listen to the news
Wedbush analyst Robert Driscoll reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and maintains $53 price target.